Follow-up in gynecological malignancies: A state of art

Paolo Zola, Chiara Macchi, David Cibula, Nicoletta Colombo, Rainer Kimmig, Tiziano Maggino, Nicholas Reed, Vesna Kesic

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Objective The main purpose of this article is to explore the current practice for follow-up of gynecological cancer, pointing out the different procedures, to determine the most clinically and cost-effective surveillance strategies after the primary treatment. Materials and Methods We analyzed the follow up strategies for ovarian, endometrial, and cervical cancer. All of the topics discussed below arose from the "ESGO State of Art Conference - Follow-up in gynaecological malignancies" in Turin, (September 11-13, 2014; http://torino2014.esgo.org/). Results Physical but these practices should be integrated with biomarkers or imaging strategies. Currently, most recommendations about follow-up are based on retrospective studies and expert opinion, and there is some disagreement on surveillance strategies due to lack of evidence-based knowledge. Conclusions All surveillance procedures should be evidence-based with a clearly defined purpose: there is a need for prospective studies to compare the effectiveness of different follow-up regimens measuring overall survival, detection of recurrence, quality of life (QoL), and costs as outcomes.

Original languageEnglish
Pages (from-to)1151-1164
Number of pages14
JournalInternational Journal of Gynecological Cancer
Volume25
Issue number7
DOIs
Publication statusPublished - Sep 5 2015

Fingerprint

Costs and Cost Analysis
Neoplasms
Expert Testimony
Endometrial Neoplasms
Uterine Cervical Neoplasms
Ovarian Neoplasms
Retrospective Studies
Biomarkers
Quality of Life
Prospective Studies
Recurrence

Keywords

  • Cervical cancer
  • Endometrial cancer
  • Follow-up
  • Ovarian cancer
  • State of art

ASJC Scopus subject areas

  • Obstetrics and Gynaecology
  • Oncology

Cite this

Follow-up in gynecological malignancies : A state of art. / Zola, Paolo; Macchi, Chiara; Cibula, David; Colombo, Nicoletta; Kimmig, Rainer; Maggino, Tiziano; Reed, Nicholas; Kesic, Vesna.

In: International Journal of Gynecological Cancer, Vol. 25, No. 7, 05.09.2015, p. 1151-1164.

Research output: Contribution to journalArticle

Zola, P, Macchi, C, Cibula, D, Colombo, N, Kimmig, R, Maggino, T, Reed, N & Kesic, V 2015, 'Follow-up in gynecological malignancies: A state of art', International Journal of Gynecological Cancer, vol. 25, no. 7, pp. 1151-1164. https://doi.org/10.1097/IGC.0000000000000498
Zola, Paolo ; Macchi, Chiara ; Cibula, David ; Colombo, Nicoletta ; Kimmig, Rainer ; Maggino, Tiziano ; Reed, Nicholas ; Kesic, Vesna. / Follow-up in gynecological malignancies : A state of art. In: International Journal of Gynecological Cancer. 2015 ; Vol. 25, No. 7. pp. 1151-1164.
@article{5a6965c9c3004c72bf35beacd87bcb20,
title = "Follow-up in gynecological malignancies: A state of art",
abstract = "Objective The main purpose of this article is to explore the current practice for follow-up of gynecological cancer, pointing out the different procedures, to determine the most clinically and cost-effective surveillance strategies after the primary treatment. Materials and Methods We analyzed the follow up strategies for ovarian, endometrial, and cervical cancer. All of the topics discussed below arose from the {"}ESGO State of Art Conference - Follow-up in gynaecological malignancies{"} in Turin, (September 11-13, 2014; http://torino2014.esgo.org/). Results Physical but these practices should be integrated with biomarkers or imaging strategies. Currently, most recommendations about follow-up are based on retrospective studies and expert opinion, and there is some disagreement on surveillance strategies due to lack of evidence-based knowledge. Conclusions All surveillance procedures should be evidence-based with a clearly defined purpose: there is a need for prospective studies to compare the effectiveness of different follow-up regimens measuring overall survival, detection of recurrence, quality of life (QoL), and costs as outcomes.",
keywords = "Cervical cancer, Endometrial cancer, Follow-up, Ovarian cancer, State of art",
author = "Paolo Zola and Chiara Macchi and David Cibula and Nicoletta Colombo and Rainer Kimmig and Tiziano Maggino and Nicholas Reed and Vesna Kesic",
year = "2015",
month = "9",
day = "5",
doi = "10.1097/IGC.0000000000000498",
language = "English",
volume = "25",
pages = "1151--1164",
journal = "International Journal of Gynecological Cancer",
issn = "1048-891X",
publisher = "Lippincott Williams and Wilkins",
number = "7",

}

TY - JOUR

T1 - Follow-up in gynecological malignancies

T2 - A state of art

AU - Zola, Paolo

AU - Macchi, Chiara

AU - Cibula, David

AU - Colombo, Nicoletta

AU - Kimmig, Rainer

AU - Maggino, Tiziano

AU - Reed, Nicholas

AU - Kesic, Vesna

PY - 2015/9/5

Y1 - 2015/9/5

N2 - Objective The main purpose of this article is to explore the current practice for follow-up of gynecological cancer, pointing out the different procedures, to determine the most clinically and cost-effective surveillance strategies after the primary treatment. Materials and Methods We analyzed the follow up strategies for ovarian, endometrial, and cervical cancer. All of the topics discussed below arose from the "ESGO State of Art Conference - Follow-up in gynaecological malignancies" in Turin, (September 11-13, 2014; http://torino2014.esgo.org/). Results Physical but these practices should be integrated with biomarkers or imaging strategies. Currently, most recommendations about follow-up are based on retrospective studies and expert opinion, and there is some disagreement on surveillance strategies due to lack of evidence-based knowledge. Conclusions All surveillance procedures should be evidence-based with a clearly defined purpose: there is a need for prospective studies to compare the effectiveness of different follow-up regimens measuring overall survival, detection of recurrence, quality of life (QoL), and costs as outcomes.

AB - Objective The main purpose of this article is to explore the current practice for follow-up of gynecological cancer, pointing out the different procedures, to determine the most clinically and cost-effective surveillance strategies after the primary treatment. Materials and Methods We analyzed the follow up strategies for ovarian, endometrial, and cervical cancer. All of the topics discussed below arose from the "ESGO State of Art Conference - Follow-up in gynaecological malignancies" in Turin, (September 11-13, 2014; http://torino2014.esgo.org/). Results Physical but these practices should be integrated with biomarkers or imaging strategies. Currently, most recommendations about follow-up are based on retrospective studies and expert opinion, and there is some disagreement on surveillance strategies due to lack of evidence-based knowledge. Conclusions All surveillance procedures should be evidence-based with a clearly defined purpose: there is a need for prospective studies to compare the effectiveness of different follow-up regimens measuring overall survival, detection of recurrence, quality of life (QoL), and costs as outcomes.

KW - Cervical cancer

KW - Endometrial cancer

KW - Follow-up

KW - Ovarian cancer

KW - State of art

UR - http://www.scopus.com/inward/record.url?scp=84940946955&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84940946955&partnerID=8YFLogxK

U2 - 10.1097/IGC.0000000000000498

DO - 10.1097/IGC.0000000000000498

M3 - Article

C2 - 26207784

AN - SCOPUS:84940946955

VL - 25

SP - 1151

EP - 1164

JO - International Journal of Gynecological Cancer

JF - International Journal of Gynecological Cancer

SN - 1048-891X

IS - 7

ER -